{'Year': '2014', 'Month': 'Mar'}
Cancer pharmacogenomics, adoption by oncologists and patient benefit.
The study aim was to understand physician experience and factors influencing the adoption of cancer pharmacogenomic (caPGx) testing by oncologists practicing in academic and nonacademic settings.